Dr Natalie Prow
Senior Research Officer, Inflammation Biology
Phone: +61 7 3362 0364
Dr Natalie Prow completed her PhD at the University of Western Australia in 2006, before gaining postdoctoral experience in the USA at University of Texas Medical Branch in Galveston and the Bloomberg School of Public Health, Johns Hopkins University, Maryland. She returned to Australia to take up a postdoctoral fellow position at the University of Queensland and was awarded an Australian Research Council postdoctoral fellowship in 2009. Dr Prow has since left the University of Queensland and is currently working as a member of the Inflammation Biology group at the QIMR Berghofer Medical Research Institute.
Dr Prow has a strong focus on the development and use of animal models for infectious diseases including the mosquito-borne flaviviruses, West Nile, Japanese encephalitis viruses and Alphaviruses, Chikungunya, Ross River and Sindbis viruses.
Dr Prow’s research interests have involved the use of molecular biology, immunology and virology to evaluate vaccine candidates, potential virulence determinants and therapeutics. In this field, Dr Prow has published 43 articles, 4 book chapters and 2 invited reviews.
Original research articles include papers in:
- The Proceedings of the National Academy of Sciences
- Emerging Infectious Diseases
- The Journal of Virology.
Dr Prow is the principal investigator in a study of the pathogenesis of an emerging mosquito-borne virus in Australia.